Toxoplasmosis, Cerebral Completed Phase 2 Trials for Leucovorin (DB00650)

Also known as: Cerebral Toxoplasmosis / Toxoplasmoses, Cerebral / Encephalitis toxoplasmal / Acquired toxoplasmal meningoencephalitis / Meningoencephalitis due to toxoplasmosis / Toxoplasmal encephalitis / Toxoplasma gondii encephalitis / Toxoplasma meningoencephalitis

IndicationStatusPhase
DBCOND0000188 (Toxoplasmosis, Cerebral)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00000643Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected PatientsPrevention
NCT00000794Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic EncephalitisTreatment